Cordex Biologics Inc.
  • About us
  • Science
  • Clinical Trials
  • News
  • Contact
  • English
    • Français
    • English
Select Page

UM171-Expanded Cell Therapy improves outcomes compared with other graft sources: Real-world evidence

by admin | Aug 8, 2023 | English

MONTREAL, August 8, 2023 – Cordex Biologics Inc., an ExCellThera Company, announced today the recent publication in Blood Advances from the American Society of Hematology of results from a safety and efficacy retrospective analysis comparing outcomes of patients...

Recent Posts

  • ExCellThera Announces International Non-proprietary Name and New Orphan Drug Designation for UM171 Cell Therapy
  • ExCellThera announces new UM171 data to be presented at ASH 2023
  • UM171-Expanded Cell Therapy improves outcomes compared with other graft sources: Real-world evidence

Recent Comments

No comments to show.

Archives

  • June 2024
  • November 2023
  • August 2023

Categories

  • English